Table 3 Univariable association of TP53 status in MOC with clinico-pathological parameters in a survival cohort combining the Genomic Analysis of Mucinous Tumors (GAMuT) and the Ovarian Tumor Tissue Analysis (OTTA) consortium.

From: Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

 

TP53 normal

TP53 abnormal

p value

MOC (N)

165

259

 

Age, mean (SE)

51.4 ± 8.6

52.1 ± 8.6

p = 0.25, t = −1.15a

Stage

 I-II

136 (85.0%)

222 (89.1%)

p = 0.22b

 III-IV

24 (15.0%)

27 (10.8%)

 

Unknown

5

10

 

Grade

 1

66 (44.9%)

84 (36.8%)

p = 0.15b

 2

66 (44.9%)

107 (46.9%)

 

 3

15 (10.2%)

37 (16.2%)

 

 Unknown

18

31

 
  1. MOC mucinous ovarian carcinoma, SD standard deviation.
  2. aWelch t test, two-sided.
  3. bFisher’s exact test, two-sided.
Back to article page